Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Share Transfer Agents of the Company, Integrated Registry Management Services Private Limited have informed the Company on the enclosed request for Loss of Share Certificate from the claimant.
14-09-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Closure of Trading Window

 This is to inform you that, in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading), 2015, read with AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading, the trading window for dealing in Equity Shares of the Company will be closed from September 16, 2023 and the same shall reopen after 48 hours from the declaration of Unaudited Financial Results of the Company for the quarter ending September 30, 2023.
14-09-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We are enclosing herewith the Certificate dated September 5, 2023 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
08-09-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agents of the Company, Integrated Registry Management Services Private Limited have informed the Company on the enclosed request for Loss of Share Certificate from the claimant.
30-08-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Voting Results and Scrutinizer''s Report of 44th Annual General Meeting of the Company held on August 14, 2023.
17-08-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Share Transfer Agents of the Company, Integrated Registry Management Services Private Limited have informed the Company on the enclosed request for Loss of Share Certificate from the claimant.
16-08-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 Summary of Proceedings of 44th Annual General Meeting.
15-08-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')

 Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015.
14-08-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Outcome Of The Board Meeting Held On Monday, August 14, 2023

 At the Board Meeting of the Company held on Monday, August 14, 2023, the Board of Directors considered and approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2023. The said Unaudited Financial Results together with the Limited Review report of the Statutory Auditors dated August 14, 2023 are enclosed herewith. The Board Meeting started at 10:30 am and concluded at 1:30 pm.
14-08-2023
Bigul

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday, August 14, 2023

 At the Board Meeting of the Company held on Monday, August 14, 2023, the Board of Directors considered and approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2023. The said Unaudited Financial Results together with the Limited Review report of the Statutory Auditors dated August 14, 2023 are enclosed herewith. The Board Meeting started at 10:30 a.m and concluded at 1:30 p.m.
14-08-2023
Next Page
Close

Let's Open Free Demat Account